Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuation Intravenous Ketamine in Major Depressive Disorder - Modification: Lithium for Relapse Prevention

NCT00548964 is registered in ClinicalTrials.gov with James Murrough as lead sponsor.

NCT NCT00548964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuation Intravenous Ketamine in Major Depressive Disorder - Modification: Lithium for Relapse Prevention
Lead sponsor
James Murrough
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2007
Completion date
July 31, 2013
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder